Over the current book year the company from Waltham could achieve a revenue around 36.09 billion USD (consensus estimates). This is hugely more than 2021's revenue of 32.22 billion USD.
The analysts expect for 2021 a net profit of 8.78 billion USD. For this year most of the analysts expect a profit per share of 22.19 USD. Based on this the price/earnings-ratio is 26.68.
Per share the analysts expect a dividend of 97 cents per share. The dividend yield is then 0.16 percent. The average dividend yield of the health care companies equals a limited 1.27 percent.
Thermo Fisher Scientific 's market capitalization is around 236.09 billion USD. 28
At 22.10 the stock trades 2.28 percent higher at 592.1 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.